Genetic analysis of SNPs have linked a variant (rs17388568) associated with increased risk of ulcerative colitis [61] and type 1 diabetes [62] with an enhanced response to anti-PD-1 in metastatic melanoma patients [63]. This evidence concerns the gene PDCD1 and type 1 diabetes mellitus.